GMV 0.00% 3.9¢ g medical innovations holdings limited

Some big hitters have joined the GMV team....

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 1,991 Posts.
    lightbulb Created with Sketch. 875
    Some big hitters have joined the GMV team.

    https://gmedinnovations.com/management/

    Mr. Oded Shahar, Adv & Notary
    Senior Investment Banker SVP,
    Merger & Acquisition
    Over 25 years of international business and banking experience and an extensive global network in which he oversaw several multi-million global deals. Held senior executive positions including Head of the Israeli branch of Crédit Agricole Corporate and Investment Bank, following hands-on experience in investment banking in Paris and private banking in Switzerland; Senior Country Officer in Israel of one of the top ten global banks; Senior Partner in one of the Israel’s leading law firms. Mr. Shahar is qualified as a lawyer and as a Notary and is a member of the Israel Bar Association. His fields of expertise are banking and international investments, mergers & acquisitions and international contracts.


    Dr. Shuki Gleitman
    Non-Executive Director
    Dr. Gleitman is the Chairman of the Guangzhuo Israel Biotech Fund, Chairman of
    the Board of Directors of Capital Point Group, a Board member and Chairman of
    the audit and financial committees of Elbit Systems (NASDAQ, TLV traded),
    Chairman of the YoYa Group, Senior Advisor to the World Bank (national policy for
    innovation) and Senior Strategy Advisor to Serbia Innovation Fund.
    Prior to holding the positions set out above, Dr. Gleitman was the Chief Scientist
    and Director General of Israel’s Ministry of Industry and Trade, where he managed
    all of the Israeli Government technological programs. In the course of his four-year
    tenure, Dr. Gleitman was responsible for allocating over $1.5 billion in grants in the
    framework of promoting research and development activities in the Israeli hightech
    industry.
    Dr. Gleitman also served as the CEO of Ampal Investment Group (NASDAQ:
    AMPL), where he was responsible for the investment of over $200 million in hightech
    ventures. During his tenure at Ampal, Dr. Gleitman led a $330 million joint
    venture with Motorola Israel founding Mirs Communications Ltd., Israel’s fourth
    largest cellular operator.
    Dr. Gleitman holds a Ph.D. (with distinction), M.Sc. (with distinction) and B.Sc. in
    Physical Chemistry, from the Hebrew University of Jerusalem.
 
watchlist Created with Sketch. Add GMV (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.